Latest News of APRE
Will Aprea Therapeutics (NASDAQ:APRE) Spend Its Cash Wisely?
By Yahoo! Finance |
2 months ago
Aprea Therapeutics' cash burn analysis shows a decent cash runway with reduced burn rate. Despite low revenue, the company's financial prudence is improving. However, its high expenditure relative to ...